With regard to Revascor (MSB/ Teva) I found it concerning that there are a number of competitors for the same indication and expecting results well before that of Revascor!
MPC-100-IM in CHF
Exhibit 5: Selected stem cell and gene therapies in Phase II or III trials for CHF Company Product Therapy class Status Target CHF patients Notes:
Mesoblast Teva Revascor Stem cell (allogeneic) Phase III-ready Ischaemic and non-ischaemic, NYHA II or III, LVEF<40 Allogeneic (bone marrow-derived) mesenchymal precursor cells (MPC). Phase III readout August 2018.
Cardio3 C-Cure Stem cell (autologous) 240-pt Phase III Ischaemic, NYHA II to IV, LVEF<30% Autologous (bone marrow-derived) cardiopoietic mesenchymal stem cells. Expected Phase III readout 2015.
Bioheart MyoCell Stem cell (autologous) 170-pt Phase II/III Ischaemic (post-AMI), NYHA II to IV, LVEF<35% Autologous (skeletal muscle-derived) myoblasts. Expected Phase II/III estimated completion February 2017.
Celladon Mydicar Gene therapy 200-pt Phase IIb Ischaemic or non-ischaemic, NHYA II to IV, LVEF<35% Gene transfer using a viral vector (AAV1) to deliver the SERCA2a gene. Expected Phase IIb readout in Q116.
Aastrom Ixmyelocel Stem cell (autologous) 108-pt Phase II Ischaemic, NYHA III or IV, LVEF<35% Autologous (bone marrow-derived) CD90+ mesenchymal cells and CD14+ monocytes. Expected Phase II readout Q315.
- Forums
- ASX - By Stock
- Edison Research
With regard to Revascor (MSB/ Teva) I found it concerning that...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.26 |
Change
-0.050(3.83%) |
Mkt cap ! $1.432B |
Open | High | Low | Value | Volume |
$1.27 | $1.30 | $1.17 | $21.32M | 17.21M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 5460 | $1.25 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.26 | 978 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 5460 | 1.250 |
3 | 38390 | 1.245 |
4 | 165443 | 1.240 |
3 | 125898 | 1.235 |
6 | 135812 | 1.230 |
Price($) | Vol. | No. |
---|---|---|
1.255 | 978 | 1 |
1.260 | 191681 | 5 |
1.265 | 127480 | 6 |
1.270 | 136662 | 4 |
1.275 | 146158 | 3 |
Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online